DIAsource ImmunoAssays S.A.
De berekende faillissementskans van DIAsource ImmunoAssays S.A. over 12 maanden bedraagt < 0,1% (zeer laag). Het bedrijf is actief sinds 1996 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 30 jaar |
| Vestigingen | 1 |
| Publicaties | 14 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2025 | volledig | 03-06-2026 | 2026-00138278 |
| 31-12-2024 | volledig | 28-05-2025 | 2025-00110978 |
| 31-12-2023 | volledig | 30-05-2024 | 2024-00103461 |
| 31-12-2022 | volledig | 02-06-2023 | 2023-00110233 |
| 31-12-2021 | volledig | 10-06-2022 | 2022-20060189 |
| 31-12-2020 | volledig | 04-05-2021 | 2021-13300248 |
| 31-12-2019 | volledig | 20-04-2020 | 2020-09500562 |
| 31-12-2018 | volledig | 17-06-2019 | 2019-19500386 |
| 31-12-2017 | volledig | 25-06-2018 | 2018-22600136 |
| 31-12-2016 | volledig | 14-06-2017 | 2017-17400385 |
| NACE primair | Gezondheidszorg(86910) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 23-05-1996 |
| Status | Actief |
| Postcode | 1348 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 25384B0035/00G000 | Wallonië | 5.338 m² | 1 · 862 m² | 10,2 m · 2 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
12-09-2023 1 bestuurder benoemd, 1 ontslagnemend
- Matej MILATA, Bestuurder
- Ondrej PALAT, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Ondrej PALAT",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Matej MILATA",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIASOURCE IMMUNOASSAYS"
}
}14-08-2023 Inge Saeys benoemd tot commissaire
- Inge Saeys, Commissaire
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Inge Saeys",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIASOURCE IMMUNOASSAYS SA"
}
}25-11-2022 Michal KOSTKA benoemd tot bestuurder
- Michal KOSTKA, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michal KOSTKA",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIASOURCE IMMUNOASSAYS"
}
}02-02-2021 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": null,
"notary": {
"name": "G\u00E9rard INDEKEU",
"firm_city": null,
"firm_name": null,
"office_city": "Louvain-La-Neuve",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2021-02-02",
"filing_date": "2021-01-22",
"act_kind_objet": "D\u00C9CISION \u00C9CRITE DES ACTIONNAIRES-CONFORM\u00C9MENT \u00C0 L\u0027ARTICLE"
},
"decision": {
"body": "bijzondere_algemene_vergadering",
"act_date": "2020-04-08",
"unanimous": true
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [],
"exchange_ratio": null,
"legal_articles": [
"536",
"552",
"23"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2019-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "Les actionnaires ont approuv\u00E9 les comptes annuels de l\u0027exercice clos le 31 d\u00E9cembre 2019, et ont donn\u00E9 d\u00E9charge aux administrateurs et au commissaire pour leur mandat. Aucun transfert de patrimoine ou restructuration juridique n\u0027est effectu\u00E9.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIAsource ImmunoAssays S.A.",
"legal_form": "Soci\u00E9t\u00E9 Anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "G\u00E9rard INDEKEU",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de DIAsource ImmunoAssays S.A. s\u0027est tenue le 8 avril 2020. Les actionnaires ont pris connaissance du rapport de gestion et du rapport annuel du commissaire, approuv\u00E9 les comptes annuels de l\u0027exercice clos le 31 d\u00E9cembre 2019, et ont donn\u00E9 d\u00E9charge aux administrateurs et au commissaire pour leur mandat. Ils ont \u00E9galement approuv\u00E9 la nomination de RSM Belgium Interaudit CV comme nouveau commissaire pour les exercices 2020 \u00E0 2022.",
"co_filed_documents": [
"Proc\u00E8s-verbal"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}22-07-2020 2 bestuurders benoemd, 1 ontslagnemend
- Béatrice de BORMAN, Bestuurder
- Ondrej PALAT, Bestuurder
- Viktor RUZICKA, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Viktor RUZICKA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "B\u00E9atrice de BORMAN",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Ondrej PALAT",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIAsource ImmunoAssays S.A."
}
}08-05-2019 Béatrice de Borman benoemd tot dagelijks bestuur
- Béatrice de Borman, Dagelijks bestuur
Technische details
{
"events": [
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "B\u00E9atrice de Borman",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIASOURCE IMMUNOASSAY"
}
}29-01-2019 1 bestuurder benoemd, 2 ontslagnemend
- Fabian Branswyk, Représentant permanent du commissaire
- VITA BVBA, Bestuurder
- Dr. Jozef Vangenechten, Gedelegeerd bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "VITA BVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Dr. Jozef Vangenechten",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant permanent du commissaire",
"person": {
"rrn": null,
"name": "Fabian Branswyk",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIASOURCE IMMUNOASSAYS"
}
}17-01-2019 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIAsource ImmunoAssays S.A."
},
"legal_form_change": {
"new": "soci\u00E9t\u00E9 anonyme",
"old": "soci\u00E9t\u00E9 anonyme",
"changed": false
}
}23-07-2018 2 bestuurders benoemd
- KPMG Réviseurs d'Entreprises SCRL civile, Commissaire aux comptes
- Christophe Habets, Représentant permanent du commissaire aux comptes
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire aux comptes",
"person": {
"rrn": null,
"name": "KPMG R\u00E9viseurs d\u0027Entreprises SCRL civile",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant permanent du commissaire aux comptes",
"person": {
"rrn": null,
"name": "Christophe Habets",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIASOURCE IMMUNOASSAYS 5A"
}
}20-09-2017 2 bestuurders benoemd, 3 ontslagnemend
- Viktor Růžička, Bestuurder
- Michal Kostka, Bestuurder
- John Hurrell, Bestuurder
- Richard Martin, Bestuurder
- Rolf Sickman, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "John Hurrell",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Richard Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Rolf Sickman",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Viktor R\u016F\u017Ei\u010Dka",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michal Kostka",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIAsource ImmunoAssays S.A."
}
}14-07-2016 2 bestuurders benoemd, 1 ontslagnemend
- VITA BVBA, Bestuurder
- Dr. John Hurrell, Bestuurder
- Dr. Geoff Cumming, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "VITA BVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Dr. Geoff Cumming",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Dr. John Hurrell",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIASOURCE IMMUNOASSAYS S.A."
}
}26-01-2016 2 bestuurders benoemd, 1 ontslagnemend
- Richard Shubrick Martin, Bestuurder
- Geoffrey James Cumming, Bestuurder
- G. Van Noord, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "G. Van Noord",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Richard Shubrick Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Geoffrey James Cumming",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIASOURCE IMMUNOASSAYS S.A."
}
}30-11-2015 Verrichting in kapitaal of aandelen
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIAsource ImmunoAssays S.A."
}
}28-10-2015 2 bestuurders benoemd
- KPMG Réviseurs d'Entreprises SCRL civile, Commissaire
- Christophe Habets, Représentant permanent du commissaire
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "KPMG R\u00E9viseurs d\u0027Entreprises SCRL civile",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant permanent du commissaire",
"person": {
"rrn": null,
"name": "Christophe Habets",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0457.934.723",
"name_full": "DIASOURCE IMMUNOASSAYS S.A."
}
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | DIAsource ImmunoAssays S.A. |